Market Overview:
The global motion sickness drugs market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of motion sickness, rising awareness about the availability of motion sickness drugs, and growing demand for over-the-counter (OTC) drugs. The global motion sickness drugs market is segmented on the basis of type into anticholinergic, antihistamines, and others. The antihistamines segment is expected to account for the largest share of the globalmotion sicknesdrugs market in 2018 owing to its high usage in both adults and children.
Product Definition:
Motion sickness is a feeling of unease or nausea caused by motion. It is most often associated with travel on boats, cars, or trains, but may also occur in amusement park rides, airplane flights, and even virtual reality headsets. Motion sickness drugs (durg) are used to relieve the symptoms of motion sickness.
Anticholinergic:
Anticholinergic is a type of drug that prevents the release of acetylcholine, a chemical messenger that helps in smooth muscle contraction and stimulates glandular secretion. It works by blocking the action of choline on parietal cells which results in reduced production of acetylcholine. As a result, it reduces the symptoms associated with motion sickness such as nausea and vomiting.
Antihistamines:
Antihistamines are generally used to relieve itching and scratching associated with insect bites, skin rashes, and other itchy conditions. They are also used to reduce the histamine response that occurs when a person is exposed to certain foods or substances that cause allergies. Antihistamines can be administered in various forms such as tablets, injections, nasal sprays and drops among others.
Application Insights:
Adults application segment held the largest share of motion sickness durg in 2017. This is due to the fact that more number of adults are traveling in ships, aircrafts and trains which results in increased prevalence of motion sickness. According to a survey conducted by cruise industry insider, around 10% to 15% people gets sick while travelling on cruise ships which amounts to USD 200 million annually. The same survey also states that 1 out of 5 people getting sick on a cruise ship will require medical attention whereas only 1 out of 100 people getting sick at home get any medical attention whatsoever.
The children application segment is expected to grow at fastest rate during forecast period owing to increasing number of kids going for adventure travel including trekking, biking.
Regional Analysis:
North America dominated the global motion sickness durg market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to increasing travel and growing adoption of air travel, high quality healthcare facilities, and rising consumer awareness about early diagnosis of diseases. Moreover, presence of key players such as Allergan Plc’s Dramamine; Merck & Co., Inc.'s Benadryl; and Mylan N.V.
Growth Factors:
- Increasing awareness about motion sickness and its prevention among people, especially travelers is expected to drive the market growth.
- Growing demand for novel and effective drugs for the treatment of motion sickness is another key factor that would fuel market growth during the forecast period.
- Rising number of cruises and sea voyages is anticipated to create opportunities for Motion Sickness Drugs manufacturers in the near future.
- Increasing research and development activities by pharmaceutical companies for developing new drugs to treat motion sickness would propel market growth over the next few years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Motion Sickness Durg Market Research Report
By Type
Anticholinergic, Antihistamines, Others
By Application
Adults, Children
By Companies
GlaxoSmithKline, Prestige Brands, WellSpring Pharmaceutical Corporation, Baxter International, Mylan, Sandoz, Pfizer, Myungmoon Pharm, Caleb Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
243
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Motion Sickness Durg Market Report Segments:
The global Motion Sickness Durg market is segmented on the basis of:
Types
Anticholinergic, Antihistamines, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Adults, Children
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GlaxoSmithKline
- Prestige Brands
- WellSpring Pharmaceutical Corporation
- Baxter International
- Mylan
- Sandoz
- Pfizer
- Myungmoon Pharm
- Caleb Pharmaceuticals
Highlights of The Motion Sickness Durg Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Anticholinergic
- Antihistamines
- Others
- By Application:
- Adults
- Children
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Motion Sickness Durg Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Motion sickness is a type of nausea and vomiting that can occur when someone experiences motion in their environment. This can include things like being on a boat, flying in an airplane, or riding in a car.
Some of the major companies in the motion sickness durg market are GlaxoSmithKline, Prestige Brands, WellSpring Pharmaceutical Corporation, Baxter International, Mylan, Sandoz, Pfizer, Myungmoon Pharm, Caleb Pharmaceuticals.
The motion sickness durg market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Motion Sickness Durg Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Motion Sickness Durg Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Motion Sickness Durg Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Motion Sickness Durg Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Motion Sickness Durg Market Size & Forecast, 2020-2028
4.5.1 Motion Sickness Durg Market Size and Y-o-Y Growth
4.5.2 Motion Sickness Durg Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Anticholinergic
5.2.2 Antihistamines
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Adults
6.2.2 Children
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Motion Sickness Durg Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Motion Sickness Durg Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Anticholinergic
9.6.2 Antihistamines
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Adults
9.10.2 Children
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Anticholinergic
10.6.2 Antihistamines
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Adults
10.10.2 Children
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Anticholinergic
11.6.2 Antihistamines
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Adults
11.10.2 Children
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Anticholinergic
12.6.2 Antihistamines
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Adults
12.10.2 Children
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Anticholinergic
13.6.2 Antihistamines
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Adults
13.10.2 Children
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Motion Sickness Durg Market: Competitive Dashboard
14.2 Global Motion Sickness Durg Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 GlaxoSmithKline
14.3.2 Prestige Brands
14.3.3 WellSpring Pharmaceutical Corporation
14.3.4 Baxter International
14.3.5 Mylan
14.3.6 Sandoz
14.3.7 Pfizer
14.3.8 Myungmoon Pharm
14.3.9 Caleb Pharmaceuticals
